newsfilter
← Latest News
Business Wire·

Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview

Launched ZUNVEYL (benzgalantamine) to US market on March 17, 2025 Secured business development licensing revenues of $2.6M for partnership with CMS Pharma Cash and cash equivalents of $45.5 million as of March 31,